Literature DB >> 29293

Gaucher disease: isolation and comparison of normal and mutant glucocerebrosidase from human spleen tissue.

P G Pentchev, R O Brady, H E Blair, D E Britton, S H Sorrell.   

Abstract

Glucocerebrosidase was purified 26,000-fold from spleens from normal humans and from patients with Gaucher disease (Gaucher spleens). The specific activities of the purified normal and mutant enzymes with glucocerebroside as substrate were 8.5 X 10(5) and 5.4 X 10(4) nmol/mg of protein per hr, respectively. The ratio of enzymatic activities was constant throughout the isolation procedure. The two enzymes appeared to be similar by other parameters such as substrate affinity, heat lability, and pH optimum. Immunotitration with glucocerebrosidase antiserum showed equivalent quantities of crossreacting material in extracts of normal and Gaucher spleens. These data strongly suggest that the genetic basis of Gaucher disease is a strucutral mutation of glucocerebrosidase. The results of sodium dodecyl sulfate gel electrophporesis also indicate that there are differences between the normal and the Gaucher disease enzyme.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 29293      PMCID: PMC392911          DOI: 10.1073/pnas.75.8.3970

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  beta-Glucoside hydrolase activity of normal and glucosylceramidotic cultured human skin fibroblasts.

Authors:  O T Mueller; A Rosenberg
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

2.  METABOLISM OF GLUCOCEREBROSIDES. II. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHER'S DISEASE.

Authors:  R O BRADY; J N KANFER; D SHAPIRO
Journal:  Biochem Biophys Res Commun       Date:  1965-01-18       Impact factor: 3.575

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Infantile (type II) Gaucher's disease: in utero diagnosis and fetal pathology.

Authors:  E L Schneider; W G Ellis; R O Brady; J R McCulloch; C J Epstein
Journal:  J Pediatr       Date:  1972-12       Impact factor: 4.406

5.  The effect of a heat-stable factor in human spleen on glucocerebrosidase and acid -glucosidase activities.

Authors:  P G Pentchev; R O Brady
Journal:  Biochim Biophys Acta       Date:  1973-02-28

6.  Isolation and characterization of glucocerebrosidase from human placental tissue.

Authors:  P G Pentchev; R O Brady; S R Hibbert; A E Gal; D Shapiro
Journal:  J Biol Chem       Date:  1973-08-10       Impact factor: 5.157

7.  Chronic Gaucher's disease: heat-resistance of leukocyte glucocerebrosidase in relation to some clinical parameters.

Authors:  C Klibansky; J Hoffman; R Zaizov; Y Matoth; J Pinkhas; A de Vries
Journal:  Biomedicine       Date:  1973-08-10

8.  Purification and properties of a heat-stable glucocerebrosidase activating factor from control and Gaucher spleen.

Authors:  S P Peters; P Coyle; C J Coffee; R H Glew
Journal:  J Biol Chem       Date:  1977-01-25       Impact factor: 5.157

9.  Autolysis of glycoproteins in rat kidney lysosomes in vitro. Effects on the isoelectric focusing behaviour of glycoproteins, arylsulphatase and beta-glucuronidase.

Authors:  A Goldstone; H Koenig
Journal:  Biochem J       Date:  1974-08       Impact factor: 3.857

10.  Enzyme replacement therapy in Gaucher's disease: large-scale purification of glucocerebrosidase suitable for human administration.

Authors:  F S Furbish; H E Blair; J Shiloach; P G Pentchev; R O Brady
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

View more
  11 in total

1.  Immunological and catalytic quantitation of splenic glucocerebrosidase from the three clinical forms of Gaucher disease.

Authors:  P G Pentchev; B Neumeyer; L Svennerholm; C G Groth; R O Brady
Journal:  Am J Hum Genet       Date:  1983-07       Impact factor: 11.025

2.  Physical and kinetic properties of beta-glucosidase in Gaucher disease.

Authors:  A Karazeh; M Carroll
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

3.  Mutations of glucocerebrosidase: discrimination of neurologic and non-neurologic phenotypes of Gaucher disease.

Authors:  E I Ginns; R O Brady; S Pirruccello; C Moore; S Sorrell; F S Furbish; G J Murray; J Tager; J A Barranger
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

4.  L-glucosylceramide: synthesis, properties, and resistance to catabolism by glucocerebrosidase in vitro.

Authors:  A E Gal; P G Pentchev; J M Massey; R O Brady
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

5.  Gaucher disease (type 1): physical and kinetic properties of liposomal and soluble 'acid' beta-glucosidase.

Authors:  M Carroll
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

6.  Cross-reacting material in Gaucher disease fibroblasts.

Authors:  E Beutler; W Kuhl; J Sorge
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

7.  Characterization of the phospholipid requirement of a rat liver beta-glucosidase.

Authors:  A Basu; R H Glew
Journal:  Biochem J       Date:  1984-12-01       Impact factor: 3.857

8.  Studies in vivo of the tissue uptake, cellular distribution and catabolic turnover of exogenous glucocerebrosidase in rat.

Authors:  S Morrone; P G Pentchev; J Baynes; S Thorpe
Journal:  Biochem J       Date:  1981-03-15       Impact factor: 3.857

9.  Isoenzymes of membrane-bound beta-glucosidase of human spleen.

Authors:  M Yaqoob; M Carroll
Journal:  Biochem J       Date:  1980-02-01       Impact factor: 3.857

10.  Gaucher disease. III. Substrate specificity of glucocerebrosidase and the use of nonlabeled natural substrates for the investigation of patients.

Authors:  F Y Choy; R G Davidson
Journal:  Am J Hum Genet       Date:  1980-09       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.